I am sure the women wil be grateful for this help. Many of them never get a chance to see a doctor.
Israeli start-up uses mobile tech to help community organizations in California battle a dread womens disease
BY DAVID SHAMAH May 30, 2014, 11:01
MobileOCTs technology uses mobile phones to detect cervical cancer in women with a device based on the principles of biophotonics. The combination of biology and photonics utilizes cameras and light to detect photons. The companys first product is a low-cost mobile colposcope, a microscope used in cervix examinations, a simple mobile phone enhanced by a lens and a set of algorithms that enable advanced screening for cancer. MobileOCTs app takes the data from the colposcope to determine the presence of cancer or pre-cancerous cells, based on photonic analysis of molecules, cells and tissue.
The Israeli company and its partners worked to conduct low-cost cervical cancer screening for 1,000 low-income immigrant patients in the area of the border between San Diego and Tijuana. The International Community Foundation plans to serve as the projects fiscal sponsor and provide additional technical expertise. The foundation has been involved in a similar multi-year mobile health clinical study in Tijuana using standard cervical cancer screening.
According to UN statistics, cervical cancer is the No. 1 cause of cancer death for poor women worldwide. In the developed world, women ages 21 to 65 undergo routine cervical cancer screening (the Pap test) at their gynecologist or gynecological clinic. The American Association of Family Physicians says that approximately 55 million women have a Pap test in the US annually. Of those, approximately 4 million women per year have an abnormal result. Women with abnormal Pap tests return for a colposcopy, a procedure in which the cervix is examined microscopically and biopsies are performed. Treatment, if necessary, can then be provided.
Read more:
MobileOCT wins prize for cancer screening program | The Times of Israel
Israeli start-up uses mobile tech to help community organizations in California battle a dread womens disease
BY DAVID SHAMAH May 30, 2014, 11:01
MobileOCTs technology uses mobile phones to detect cervical cancer in women with a device based on the principles of biophotonics. The combination of biology and photonics utilizes cameras and light to detect photons. The companys first product is a low-cost mobile colposcope, a microscope used in cervix examinations, a simple mobile phone enhanced by a lens and a set of algorithms that enable advanced screening for cancer. MobileOCTs app takes the data from the colposcope to determine the presence of cancer or pre-cancerous cells, based on photonic analysis of molecules, cells and tissue.
The Israeli company and its partners worked to conduct low-cost cervical cancer screening for 1,000 low-income immigrant patients in the area of the border between San Diego and Tijuana. The International Community Foundation plans to serve as the projects fiscal sponsor and provide additional technical expertise. The foundation has been involved in a similar multi-year mobile health clinical study in Tijuana using standard cervical cancer screening.
According to UN statistics, cervical cancer is the No. 1 cause of cancer death for poor women worldwide. In the developed world, women ages 21 to 65 undergo routine cervical cancer screening (the Pap test) at their gynecologist or gynecological clinic. The American Association of Family Physicians says that approximately 55 million women have a Pap test in the US annually. Of those, approximately 4 million women per year have an abnormal result. Women with abnormal Pap tests return for a colposcopy, a procedure in which the cervix is examined microscopically and biopsies are performed. Treatment, if necessary, can then be provided.
Read more:
MobileOCT wins prize for cancer screening program | The Times of Israel
